Abstract:The ARH family of ADP-ribose-acceptor hydrolases consists of three 39-kDa members (ARH1-3), with similarities in amino acid sequence. ARH1 was identified based on its ability to cleave ADP-ribosyl-arginine synthesized by cholera toxin. Mammalian ADP-ribosyltransferases (ARTCs) mimicked the toxin reaction, with ARTC1 catalyzing the synthesis of ADP-ribosyl-arginine. ADP-ribosylation of arginine was stereospecific, with β-NAD+ as substrate and, α-anomeric ADP-ribose-arginine the reaction product. ARH1 hydrolyzed α-ADP-ribose-arginine, in addition to α-NAD+ and O-acetyl-ADP-ribose. Thus, ADP-ribose attached to oxygen-containing or nitrogen-containing functional groups was a substrate. Arh1 heterozygous and knockout (KO) mice developed tumors. Arh1-KO mice showed decreased cardiac contractility and developed myocardial fibrosis. In addition to Arh1-KO mice showed increased ADP-ribosylation of tripartite motif-containing protein 72 (TRIM72), a membrane-repair protein. ARH3 cleaved ADP-ribose from ends of the poly(ADP-ribose) (PAR) chain and released the terminal ADP-ribose attached to (serine)protein. ARH3 also hydrolyzed α-NAD+ and O-acetyl-ADP-ribose. Incubation of Arh3-KO cells with H2O2 resulted in activation of poly-ADP-ribose polymerase (PARP)-1, followed by increased nuclear PAR, increased cytoplasmic PAR, leading to release of Apoptosis Inducing Factor (AIF) from mitochondria. AIF, following nuclear translocation, stimulated endonucleases, resulting in cell death by Parthanatos. Human ARH3-deficiency is autosomal recessive, rare, and characterized by neurodegeneration and early death. Arh3-KO mice developed increased brain infarction following ischemia-reperfusion injury, which was reduced by PARP inhibitors. Similarly, PARP inhibitors improved survival of Arh3-KO cells treated with H2O2. ARH2 protein did not show activity in the in vitro assays described above for ARH1 and ARH3. ARH2 has a restricted tissue distribution, with primary involvement of cardiac and skeletal muscle. Overall, the ARH family has unique functions in biological processes and different enzymatic activities.

Expression analysis of type I ARF small GTPases ARF1-3 during mouse brain development

Expression Analysis of the NDRG2 Gene in Mouse Embryonic and Adult Tissues

Variations associated with neurodevelopmental disorders affect ARF1 function and cortical development

[Expression of Neural Salient Serine/arginine-Rich Protein 1 (NSSR1) in the Development of Mouse Brain].

The small GTPase ARF6 regulates GABAergic synapse development

Research Progress in ARF-GEF Gene Family

Regulated Shuttling of Slit-Robo-GTPase Activating Proteins Between Nucleus and Cytoplasm During Brain Development

ARH Family of ADP-Ribose-Acceptor Hydrolases

The Expression and Distributions of Anp32a in the Developing Brain

Localisation and role of activin receptor-interacting protein 1 in mouse brain

Characterization, Chromosomal Assignment, and Tissue Expression of A Novel Human Gene Belonging to the Arf Gap Family

Brain‐specific Potential Guanine Nucleotide Exchange Factor for Arf, Synarfgef (po), is Localized to Postsynaptic Density

Arf-like GTPases: not so Arf-like after all

Arl2 Associates with Cdk5rap2 to Regulate Cortical Development via Microtubule Organization

Arl2 GTPase associates with the centrosomal protein Cdk5rap2 to regulate cortical development via microtubule organization

The Small G Proteins of the Arf Family and Their Regulators

Cloning and Characterization of the Mouse Arht2 Gene Which Encodes a Putative Atypical GTPase.

Clinical and Molecular Characterization of Three Novel ARHGEF9 Mutations in Patients with Developmental Delay and Epilepsy

Expression pattern of growth/differentiation factor 3 in human and murine cerebral cortex, hippocampus as well as cerebellum.

ArfGAP1 acts as a GTPase‐activating protein for human ADP‐ribosylation factor‐like 1 protein

Brefeldin A‐inhibited Guanine Nucleotide Exchange Protein 3 is Localized in Lysosomes and Regulates GABA Signaling in Hippocampal Neurons